Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Halotherapy - A possible method to enhance airway treatment on patients with obstructive pathology

Radu Crisan - Dabija, Traian Mihaescu
European Respiratory Journal 2012 40: P2165; DOI:
Radu Crisan - Dabija
1Pneumology, Hospital of Respiratory Diseases, Iasi, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Traian Mihaescu
2Pneumology, University of Medicine and Pharmacy, Iasi, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Introduction: The clinical benefits of halotherapy is advocated, but the mechanisms are scarcely studied and there is not enough available clinical data. Halotherapy may influence mucolysis, antibacterial and anti-inflammatory actions, also the immunomodulator - hyposensibilizing agents. We conducted a perspective study where we use a dry-salt inhaler on patients with asthma and COPD.

Methods: The study was double-blind, randomized trial, single crossed, conducted for 4 months with 4 visits (V1 - V4). The total patient population - 128 individuals (76 - asthma and 52 - COPD stages II and III) was divided in 2 arms, crossed after first visit (V1). We instructed the patients to use the salt-inhaler 20 minutes/day. We analyzed the evolution of spirometry parameters FVC, FEV1 and PEF and a Quality of Life Questionnaire with 5 items concerning: the quality of sleep and the simptomatology.

Results: The study revealed an improvement of all spirometry parameters after the first month of treatment with

salt aerosols versus placebo. The final data showed an overall improvement of FVC by 4%, 14% improvement of the FEV1 and 25% improvement of PEF parameter - showing significant improvement

in asthma patients condition. Correlating quality of life responses we found out that they were improved throughout the study by 24% showing a significant impact on the quality of life.

Conclusions

Correlating both the improvements of spirometry parameters and the scores from the QoL questionnaire we found that the NaCl aerosols from a dry salt inhaler (home halotherapy) seems to be efficient versus placebo when added to regular bronchodilatatory medication but further studies are necessary.

  • Airway management
  • Quality of life
  • Treatments
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Halotherapy - A possible method to enhance airway treatment on patients with obstructive pathology
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Halotherapy - A possible method to enhance airway treatment on patients with obstructive pathology
Radu Crisan - Dabija, Traian Mihaescu
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2165;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Halotherapy - A possible method to enhance airway treatment on patients with obstructive pathology
Radu Crisan - Dabija, Traian Mihaescu
European Respiratory Journal Sep 2012, 40 (Suppl 56) P2165;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Direct activation of sensory afferents by diesel exhaust particles can trigger respiratory symptoms
  • Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression
  • Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model
Show more 5.1 Airway Pharmacology and Treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society